Gerresheimer has announced that production of its US dropper bottles with a fixed TE-ring will be operational in Q3.

Produced in Poland, India and the US, the TE-ring is fixed to the Type A Eye-Dropper Bottle to meet new US Food and Drug Administration (FDA) regulations

Global executive vice-president at Gerresheimer Plastic Packaging Niels Düring said: “It’s often the technical details that add the finishing touches to packaging.”

TE-ring now firmly attached to the bottle

The US Food and Drug Administration (FDA) now stipulate that the TE-ring must be firmly attached to the bottle. This product change was very easy to make, due to experience with the type B dropper bottle, which already has a fixed TE-ring.

Only minor adjustments were made to the design, while the dimensions, properties, and the materials are the same. The bottle and the dropper are made from low-density polyethylene (LDPE) and the cap from high-density polyethylene (HDPE). The existing type A dropper bottles can therefore be used for stability tests.

Gerresheimer produces type A dropper bottles holding 2ml to 360ml under cleanroom conditions. Depending on the size of the container, they are produced using the injection blow molding (IBM) or the extrusion blow molding (EBM) process. Radiation or ethylene oxide (ETO) sterilisation is possible on request. All caps protect the original contents and can also be supplied with a child-proof screw cap.